Psychosis treatment prior to psychosis onset: Ethical issues

Schizophrenia Research

Volumn 51, Issue 1, 2001, Pages 47-54

  McGlashan, Thomas H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antipsychotic treatments; Psychosis; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

CLINICAL TRIAL; COGNITIVE DEFECT; CONFERENCE PAPER; DISEASE COURSE; DYSPHORIA; ETHICS; HIGH RISK POPULATION; HUMAN; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSIS; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; SYMPTOMATOLOGY; TARDIVE DYSKINESIA; TYPES OF STUDY;

ANTIPSYCHOTIC AGENTS; CLINICAL TRIALS; ETHICS, MEDICAL; HUMANS; PROGNOSIS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; TREATMENT OUTCOME;

EID: 0035424677     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(01)00238-9     Document Type: Conference Paper

References (25)

1. Olanzapine versus placebo and haloperidol: Acute phase results of the North American double-blind olanzapine trial
2. Olanzapine versus haloperidol: Acute phase results of the international double-blind olanzapine trial
3. Randomized double-blind comparison of the incidence of tardive dyskensia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol
4. Early intervention for first episodes of schizophrenia: A preliminary exploration
5. Equipoise and the ethics of clinical research
6. Threats to the validity of multi-site, longitudinal studies of first-episode schizophrenia
7. Expected incidence of tardive dyskinesia associated with atypical antipsychotics
8. Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality
9. Community equipoise and the architecture of clinical research
10. First-episode schizophrenia: Reducing delays in treatment
11. Early detection and intervention in schizophrenia
12. Early detection and intervention in schizophrenia research
13. Duration of untreated psychosis in first-episode schizophrenia: Marker or determinant of course?
14. Treating schizophrenia earlier in life and the potential for prevention
15. Schizophrenia as a disorder of developmentally reduced synaptic connectivity
16. Early detection and intervention with schizophrenia: Rationale
17. Preventative strategies in early psychosis: Verging on reality
18. Preventative interventions in the prepsychotic phase-Panacea, Pipedreams or Pandora's Box?
19. Identifying youth at risk before onset
20. Symptom assessment in schizophrenic prodromal states
21. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: Results of an international collaborative trial
22. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskensia with olanzapine or haloperidol
23. Monitoring and care of young people at incipient risk of psychosis
24. Prediction of psychosis